theheart.org: Cardiology news, educational programming, and opinions

Editorial series

Jun 29, 2009 11:00 EDT

Dr Robert Harrington talks to Drs Sanjay Kaul and Harlan Kurmholz about the SYNTAX trial in light of the recent quality-of-life and cost analysis.

Editorial series

Getting to the bottom of BARI 2D

Jun 25, 2009 00:03 EDT

Join Drs Valentin Fuster, William E Boden, and George D Dangas as they discuss the results, plus the evolution of therapy over the last forty years, the mechanisms of coronary artery disease progression in diabetic patients, and what is perhaps one of the most fundamental problems in the field: that patients today are still not treated to target with best medical therapy.

Editorial series

After TIPS: What's next for the polypill?

Jun 15, 2009 09:30 EDT

Join Drs Salim Yusuf and Sanjay Kaul for an in-depth discussion on the promise and prospects of the polypill moderated by heartwire's Lisa Nainggolan.

Editorial series

Hypertrophic cardiomyopathy, athletes, and screening

Jun 5, 2009 09:30 EDT

Is it possible and desirable to envisage a nationwide system to screen athletes for hypertrophic cardiomyopathy? Drs Ommen, Maron, and Thompson examine the Italian screening data and review the implications of this model for the US.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Steve Nissen

1 COMMENT - Jun 1, 2009 10:20 EDT

Join Dr Robert Califf for a probing and personal interview with Dr Steven Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.

Editorial series

Strategies for GP IIb/IIIa blockers after EARLY ACS

May 22, 2009 09:20 EDT

Dr Harlan Krumholz talks to Drs Sanjay Kaul and Robert Harrington about EARLY ACS and the issues around upstream use of GP IIb/IIIa inhibitors.

Editorial series

ACC 2009: Update on heart failure

May 12, 2009 15:15 EDT

Drs Melissa Walton-Shirley and Clyde Yancy review the latest data on heart failure from ACC 2009, including STICH, Pre-RELAX-AHF, PRIMA, and more.

Editorial series

Cardiac catheterization access sites: An international perspective

1 COMMENT - Apr 29, 2009 00:00 EDT

With the global trend leaning toward increased use of transradial access, our international panel reports on standard practice at their respective institutions and the key issues that influence it such as bleeding, access-site complications, stroke risk, patient mobility, and operator experience. Join Drs Kandzari (US), Feres (Brazil), Le May (Canada), and Steg (France) for this thoughtful and practical discussion.

The Cardiology Show

ACC 2009: From the eye of the storm in Orlando

Apr 2, 2009 15:35 EDT

Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.

Editorial series

Beyond Natriuretic Peptides: ST2 in Heart Failure

Mar 9, 2009 08:00 EDT

What role is there for new biomarkers in the biological management of heart failure? Join Dr James Januzzi as he discusses the role of ST2 in this rapidly expanding field and how ST2 can help to improve the care of patients with heart failure.

Cardiology panels

Putting HF-ACTION into practice

Feb 27, 2009 10:00 EST

Join Dr Melissa Walton-Shirley as she talks to Drs Mariell Jessup and Clyde Yancy about the importance of the HF-ACTION study and how the quality-of-life results should affect practice.

Editorial series

Get Moving: The 2008 Physical Activity Guidelines for Americans

2 COMMENTS - Feb 20, 2009 09:00 EST

The US government has issued the first-ever Physical Activity Guidelines for Americans. Join our expert panel, Steven Blair PED, Drs Timothy Church, and William Kraus, as they discuss the implications and strategies for using these guidelines in clinical practice.

Editorial series

Structured exercise for your heart-failure patients?

1 COMMENT - Feb 13, 2009 13:53 EST

What is the role of a structured exercise program for your patients with NYHA class 2/3 heart failure? Join Dr Ileana Piña's presentation of the results of HF-ACTION, presented at AHA, and the implications of the findings for patient care.

Cardiology panels

CRP strategy post-JUPITER

Feb 6, 2009 10:25 EST

Join heartwire's Michael O'Riordan as he talks to Dr Roger Blumenthal about the potential pitfalls of jumping on the CRP bandwagon post-JUPITER and what can be done to reduce risk factors from a preventive point of view.

Cardiology panels

What patients believe about PCI: Misunderstanding or misinformation?

1 COMMENT - Jan 28, 2009 09:00 EST

Drs Gregg Stone and William Weintraub discuss the misconceptions some patients have about the benefits and purpose of elective PCI and what can be done to rectify them in a candid discussion moderated by heartwire's Shelley Wood.

HeartWire clips

Face-to-face with Dr Melissa Walton-Shirley: From the AHA with Dr Sidney Smith

Dec 16, 2008 13:00 EST

Join theheart.org's forum moderator in these in-depth interviews filmed on location at major congresses

Cardiology panels

Beyond COURAGE

Dec 12, 2008 17:00 EST

Join Drs Harrington, Stone, and Weintraub as they discuss the world of revascularization from COURAGE and beyond, including lessons learned from SYNTAX and FAME, and the questions they hope will be answered by the ongoing PROSPECT trial.

Editorial series

Lipid lowering: The end or the means?

3 COMMENTS - Dec 9, 2008 16:46 EST

Dr Blumenthal talks to Drs Krumholz, Ridker, and Smith about how to approach target guidelines for LDL in the wake of JUPITER, SEARCH, and other lipid-lowering studies.

Ten years in review

Reviewing 10 years of cardiology news

Dec 3, 2008 14:30 EST

As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?

Cardiology panels

Cardiovascular implications of treating type 2 diabetes, post-APPROACH

4 COMMENTS - Dec 3, 2008 09:30 EST

How best to treat patients presenting with both coronary disease and diabetes? Join Drs Nesto and Fonseca on this rather slippery slope as they examine the data and provide practical guidance for treatment.

The Cardiology Show

AHA 2008: The AHA Flies to JUPITER

3 COMMENTS - Nov 14, 2008 12:00 EST

Join Drs Krumholz, Blumenthal, Harrington, Jessup, Ridker, Smith, Stone, Weintraub, and Yancy as they dissect the results of the JUPITER and debate the far-reaching clinical implications of this landmark study in Part 1 of the program. In Part 2, the panelists look at the positive sides of HF-Action and TIMACS and deliberate the real lessons learned from these negative trials.

Cardiology panels

Dual RAS inhibition: Weighing the evidence

Nov 4, 2008 14:31 EST

Dr Melissa Walton-Shirley asks Drs Franz Messerli and Raymond Gibbons for their thoughts on dual RAAS inhibition and on what the future holds for ACE inhibitors and angiotensin-receptor blockers following ONTARGET and TRANSCEND.

Cardiology panels

COURAGE: 18 months later

Oct 28, 2008 12:00 EDT

Join Drs Raymond Gibbons, Antonio Colombo, William Boden, Ph Gabriel Steg, and Valentin Fuster for another look at the COURAGE trial, as they discuss the latest data and talk about where things stand now on the larger controversy.

Cardiology panels

A look at STEMI care on both sides of the Atlantic

Oct 22, 2008 09:20 EDT

Dr Melissa Walton-Shirley talks to Drs Ph Gabriel Steg and Raymond Gibbons about the differences in STEMI care on both sides of the Atlantic and what US cardiologists can learn from their colleagues in Europe.

Cardiology panels

TRANSCEND: More questions than answers?

Oct 15, 2008 09:41 EDT

Join Drs Marc Pfeffer, Philip Poole-Wilson, and Franz Messerli, as they talk about the use of ARBs in patients intolerant of ACE inhibitors, following the unexpected results of the TRANSCEND study, in a spirited debate moderated by heartwire journalist Lisa Nainggolan.

	Yes
	No